- Medical Research Scotland PhD studentship award winners - 2020- SMART Scotland Grant winners - 2018- Animal Health Investment Europe showcase finalists - London 2018- Informa Disruptors & innovators report 2018 Top 20 Animal Health start-upsN2 Pharmaceuticals has developed and patented a proprietary method to extract bioactive peptides (N2-01) from Mytilus edulis. N2-01 has already been used in 25,000+ farm and companion animals and is proven to reduce mortality in multiple conditions associated with endothelial dysfunction, including Porcine circovirus type 2. In studies to date, N2-01 has been shown to significantly reduce endothelial dysfunction and vascular leakage in human endothelial cells.Based in Edinburgh, N2 Pharmaceuticals intend to repurpose N2-01 from animal health applications to treat a number of acute human diseases associated with endothelial dysfunction.

Having a solid experience in project management both in the UK and in Russia, I joined N&A Communications’ business development team to manage their international projects. About N&A Communications:www.na-communications.comN&A COMMUNICATIONS offers a complete range of consultancy services in the areas of PR and business development in Europe and Russia. Over the years the company has successfully implemented a large number of projects in different industries including tourism, sports, medical care, IT and retail. Our clients range from promising start-ups to multinational companies.The experience in project management together with our knowledge of international markets and our business contacts enables us to deliver the results our clients expect.

Being responsible for the Company’s business in Russia and the CIS region my key objective is to establish both the Klarius and Quinton Hazell brands in these markets, while providing sustainable long-term growth in sales as well as profit maximization for the Group.

My role involved the identification of major opportunities for the Company in foreign markets as well as the development of penetration strategies for those markets.Key responsibilities:- Quantitative and qualitative research of the potential markets. This process involved travelling to the new markets obtaining information from the key players as well as using secondary informational sources to form a complete understanding of the market situation and opportunities for the Company.- Making decisions on the potential of the markets- Development of penetration strategies for potentially profitable territories- Presentation of the findings to the Board of Directors. - Implementation of the penetration strategies in the markets (Russia and CIS)